| Product Code: ETC070009 | Publication Date: Aug 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Vietnam Contract Cell and Gene Therapy Manufacturing Market was estimated at USD 1101 Million in 2025 and is projected to reach USD 1564 Million by 2032, growing at a CAGR of 5.1% from 2026 to 2032. This growth trajectory is primarily fueled by the increasing demand for personalized medicine and the robust advancements in biotechnology. Moreover, a surge in collaborations between biopharmaceutical companies and contract manufacturing organizations (CMOs) is propelling innovation and efficiency in therapy production.
This graph highlights how the Vietnam Contract Cell and Gene Therapy Manufacturing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.1% | Increasing smart city development projects |
| 2022 | 3.2% | Increasing industrial infrastructure investments |
| 2023 | 8.1% | Growing urbanization and commercial development |
| 2024 | 5.6% | Rapid growth in telecom and data center sectors |
| 2025 | 7.0% | Rising electricity demand across industries |
| 2026 | 8.1% | Increasing smart city development projects |
| 2027 | 7.5% | Growing renewable energy integration projects |
| 2028 | 6.5% | Increasing industrial automation investments |
| 2029 | 6.1% | Expansion of commercial construction activities |
| 2030 | 6.0% | Increasing smart city development projects |
| 2031 | 5.9% | Rapid growth in telecom and data center sectors |
| 2032 | 5.3% | Government infrastructure modernization initiatives |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The foremost driving force behind the Vietnam Contract Cell and Gene Therapy Manufacturing Market is the growing emphasis on personalized medicine. As more therapies are tailored to individual patient needs, CMOs are rising to the challenge, providing essential support for bringing these innovative treatments to market.
Additionally, significant investments in research and development underscore the potential of cell and gene therapies to address unmet medical needs. With government support and a favorable regulatory environment, the market is poised for a remarkable transformation, aligning Vietnam as a key player in the global landscape of advanced therapies.
Despite its promising outlook, the Vietnam Contract Cell and Gene Therapy Manufacturing Market faces several constraints. High production costs associated with advanced therapies and the specialized expertise required for their manufacturing serve as notable barriers. Establishing state-of-the-art facilities that meet the unique demands of cell and gene therapy production involves considerable investment. Furthermore, the challenge of attracting and retaining a skilled workforce in this rapidly evolving domain remains a significant concern, impacting operational capabilities.
A prominent trend shaping the market is the increasing integration of automation and digital technologies in manufacturing processes. This shift not only enhances efficiency but also reduces human error, which is critical in high-stakes therapy production. Additionally, there is a noticeable rise in partnerships among research institutions and CMOs, aimed at accelerating the development of innovative therapies. These collaborations are expected to spur breakthroughs in treatment options, further driving the market's growth.
Significant growth opportunities exist in the Vietnam Contract Cell and Gene Therapy Manufacturing Market, particularly in expanding production capabilities for both local and international companies. The increasing demand for personalized medicine presents a ripe avenue for investment in advanced manufacturing facilities. Moreover, fostering international partnerships can accelerate technological transfer and innovation, allowing Vietnam to position itself as a competitive hub for cell and gene therapy manufacturing in the Asia-Pacific region.
The Vietnamese government is actively promoting the development of the biotechnology sector through various initiatives and policy frameworks. Public spending on healthcare and biotechnology research is on the rise, with specific programs designed to support the growth of advanced therapies. Incentives for foreign investments in the biomanufacturing landscape are also being implemented, aiming to enhance Vietnam's capabilities in producing cutting-edge therapies.
Looking ahead to 2026-2032, the Vietnam Contract Cell and Gene Therapy Manufacturing Market is poised for substantial expansion. The continued evolution of regulatory frameworks will likely facilitate faster approval processes for innovative therapies. Furthermore, as technology advances and becomes more accessible, the cost of manufacturing cell and gene therapies is expected to decline. This will create more opportunities for a broader range of companies to engage in the market, enhancing overall competition and innovation.
Recent developments in the Vietnam Contract Cell and Gene Therapy Manufacturing Market indicate a focus on enhancing biomanufacturing capabilities. There has been a notable uptick in international collaborations aimed at improving production technologies and methodologies. Efforts to establish training programs for skilled personnel are also gaining momentum, reflecting the sector's commitment to addressing workforce challenges and supporting sustainable growth.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Vietnam Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2022 & 2032F |
3.6 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2022 & 2032F |
4 Vietnam Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Vietnam Contract Cell and Gene Therapy Manufacturing Market, By Types |
6.1 Vietnam Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2022-2032F |
6.1.3 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2022-2032F |
6.1.4 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2022-2032F |
6.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2022-2032F |
6.2.3 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2022-2032F |
6.2.4 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2022-2032F |
6.2.5 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2022-2032F |
7 Vietnam Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Vietnam Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Vietnam Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
9 Vietnam Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Vietnam Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2022 & 2032F |
9.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2022 & 2032F |
10 Vietnam Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here